Innospec Inc. (IOSP) Income Statement
IOSP 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsIOSP revenue and net income
Where IOSP's revenue goes
2025Each bar shows an amount and its share of revenue. IOSP kept 6.6% of revenue as net income.
IOSP profit margins
IOSP growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −3.7% | −3.3% | +8.3% | +5.8% |
| Gross profit | −9.3% | −5.7% | +7.5% | +3.6% |
| Operating income | −12.1% | −5.9% | +35.9% | 0.0% |
| Net income | +227.5% | −4.3% | +32.4% | −0.2% |
| EPS (diluted) | −10.2% | −4.3% | +10.5% | +2.0% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
IOSP quarterly EPS vs estimates
Innospec beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: November 3, 2026 (estimate $1.28).
IOSP income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.78B | $1.85B | $1.95B | $1.96B | $1.48B | $1.19B | $1.51B | $1.48B | $1.31B | $883.4M |
| Cost of revenue | $1.29B | $1.30B | $1.36B | $1.38B | $1.05B | $850.4M | $1.05B | $1.04B | $903.5M | $551.1M |
| Gross profit | $492.4M | $542.9M | $591.1M | $586.7M | $434.9M | $342.7M | $466.2M | $435.0M | $403.3M | $332.3M |
| Research & development | $51.0M | $47.8M | $41.7M | $38.7M | $37.4M | $30.9M | $35.4M | $33.4M | $31.4M | $25.4M |
| Sales, general & admin | $285.1M | $314.0M | $382.1M | $360.7M | $267.2M | $237.0M | $261.3M | $238.1M | $220.2M | $196.8M |
| Total operating expenses | $336.1M | $365.0M | $429.5M | $399.4M | $302.8M | $309.0M | $316.3M | $294.4M | $270.9M | $234.9M |
| Operating income | $156.3M | $177.9M | $161.6M | $187.3M | $132.1M | $33.7M | $149.9M | $133.5M | $129.7M | $105.4M |
| Interest income | — | — | — | — | — | — | $6.7M | $7.6M | $1.6M | $10.5M |
| Interest expense | — | — | $2.3M | $1.1M | $1.5M | $1.8M | $4.8M | $6.9M | $8.2M | $3.2M |
| Income before taxes | $138.1M | $41.2M | $174.4M | $184.6M | $134.4M | $39.7M | $150.4M | $131.6M | $128.1M | $103.1M |
| Income taxes | $21.5M | $5.6M | $35.3M | $51.6M | $41.3M | $11.0M | $38.2M | $46.6M | $66.3M | $21.8M |
| Net income | $116.6M | $35.6M | $139.1M | $133.0M | $93.1M | $28.7M | $112.2M | $85.0M | $61.8M | $81.3M |
| EBITDA | $181.7M | $224.6M | $213.7M | $225.8M | $173.0M | $87.5M | $206.2M | $194.2M | $191.9M | $144.0M |
| EPS (diluted) | $5.30 | $5.90 | $6.09 | $6.05 | $4.81 | $3.22 | $5.24 | $4.84 | $4.63 | $3.83 |
| Gross margin | 27.7% | 29.4% | 30.3% | 29.9% | 29.3% | 28.7% | 30.8% | 29.5% | 30.9% | 37.6% |
| Operating margin | 8.8% | 9.6% | 8.3% | 9.5% | 8.9% | 2.8% | 9.9% | 9.0% | 9.9% | 11.9% |
| Net margin | 6.6% | 1.9% | 7.1% | 6.8% | 6.3% | 2.4% | 7.4% | 5.8% | 4.7% | 9.2% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $491.4M | $453.2M | $455.6M | $441.9M | $439.7M | $440.8M | $466.8M | $443.4M | $435.0M | $500.2M | $494.7M | $464.1M |
| Cost of revenue | $353.1M | $329.7M | $328.2M | $325.2M | $316.5M | $315.7M | $330.6M | $319.3M | $308.1M | $344.5M | $339.0M | $326.9M |
| Gross profit | $138.3M | $123.5M | $127.4M | $116.7M | $123.2M | $125.1M | $136.2M | $124.1M | $126.9M | $155.7M | $155.7M | $137.2M |
| Research & development | $14.2M | $13.2M | $11.0M | $13.7M | $13.6M | $12.7M | $12.7M | $11.1M | $14.0M | $14.0M | $8.9M | $11.6M |
| Sales, general & admin | $84.3M | $78.5M | $69.3M | $71.9M | $74.6M | $69.4M | $227.9M | $66.8M | $72.0M | $90.5M | $102.3M | $81.9M |
| Total operating expenses | $98.6M | $91.7M | $80.3M | $85.6M | $88.9M | $82.6M | $95.1M | $78.5M | $86.2M | $105.2M | $111.2M | $95.3M |
| Operating income | $39.7M | $31.8M | $47.1M | $31.1M | $34.3M | $42.5M | $41.1M | $45.6M | $40.7M | $50.5M | $44.5M | $41.9M |
| Interest income | $800,000 | — | — | $2.2M | $2.7M | — | — | — | — | — | — | — |
| Interest expense | — | — | — | — | — | — | — | — | $2.1M | — | $900,000 | $800,000 |
| Income before taxes | $41.6M | $39.9M | $50.3M | $11.5M | $31.9M | $44.4M | −$102.6M | $44.8M | $43.7M | $55.3M | $45.3M | $47.5M |
| Income taxes | $10.4M | $9.1M | $2.9M | −$1.4M | $8.4M | $11.6M | −$32.2M | $11.4M | $12.5M | $13.9M | $7.5M | $8.3M |
| Net income | $30.8M | $30.4M | $47.4M | $12.9M | $23.5M | $32.8M | −$70.4M | $33.4M | $31.2M | $41.4M | $37.8M | $39.2M |
| EBITDA | $47.8M | $49.8M | $59.7M | $23.7M | $46.1M | $53.9M | $48.3M | $59.0M | $52.4M | $63.3M | $55.5M | $53.6M |
| EPS (diluted) | $1.27 | $1.05 | $1.50 | $1.12 | $1.26 | $1.42 | $1.41 | $1.35 | $1.39 | $1.75 | $1.84 | $1.59 |
| Gross margin | 28.1% | 27.3% | 28.0% | 26.4% | 28.0% | 28.4% | 29.2% | 28.0% | 29.2% | 31.1% | 31.5% | 29.6% |
| Operating margin | 8.1% | 7.0% | 10.3% | 7.0% | 7.8% | 9.6% | 8.8% | 10.3% | 9.4% | 10.1% | 9.0% | 9.0% |
| Net margin | 6.3% | 6.7% | 10.4% | 2.9% | 5.3% | 7.4% | −15.1% | 7.5% | 7.2% | 8.3% | 7.6% | 8.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in IOSP's financial statements (latest annual report filed February 18, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
IOSP financial results
In fiscal year 2025 (ended December 31, 2025), Innospec reported revenue of $1.8 billion, down 3.7% from the year before. It had net income of $116.6 million (up 227.5%), a net profit margin of 6.6%. Diluted earnings per share came to $5.30. Over five years revenue grew at an average rate of 8.3% a year.
See the IOSP stock overview for the latest quote and news, or the IOSP chart for price history and technical indicators.
IOSP income statement FAQ
What is Innospec's annual revenue?
Innospec reported total revenue of $1.8 billion for fiscal year 2025, which ended on December 31, 2025. That was down 3.7% from $1.8 billion the previous year.
Is Innospec profitable?
Yes. Innospec reported net income of $116.6 million in fiscal 2025, a net profit margin of 6.6%; its operating margin was 8.8%.
What is Innospec's gross margin?
Innospec's gross margin was 27.7% in fiscal 2025: for every $100 of revenue, Innospec kept $28 after the direct cost of its products and services.
How much does Innospec spend on research and development?
Innospec spent $51.0 million on research and development in fiscal 2025, 2.9% of revenue.
How fast is Innospec growing?
Revenue grew 8.3% a year on average over the last five fiscal years, from $1.2 billion to $1.8 billion.
What are Innospec's earnings per share?
Innospec earned $5.30 per diluted share in fiscal 2025, compared with $5.90 a year earlier.
When will Innospec report its next earnings?
Innospec is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 after the market closes.
When does Innospec's fiscal year end?
Innospec's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 18, 2026.